acetazolamide has been researched along with Infarction, Middle Cerebral Artery in 14 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was aimed at testing the hypothesis that regional cerebrovascular reactivity (rCVR) to acetazolamide can be a reliable predictor of subsequent ischemic stroke in medically treated patients with internal carotid artery or middle cerebral artery occlusion." | 5.09 | Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? ( Abe, H; Houkin, K; Iwasaki, Y; Kamiyama, H; Kuroda, S; Mitsumori, K, 2001) |
| " antiplatelet therapy), indicating a repeat TIA or ischemic stroke attack was noted during maximal medical therapy; having poor cerebral perfusion on CT imaging; and having regional cerebrovascular reactivity (rCVR) of <20% when acetazolamide challenge was undergone." | 3.78 | Extracranial-intracranial (EC-IC) bypass of symptomatic middle cerebral artery (MCA) total occlusion for haemodynamic impairment patients. ( Chang, JH; Chen, CC; Cheng, YW; Cho, DY; Chou, CW; Lin, SZ, 2012) |
| "Cumulative recurrence-free survival rates in all patients, and in each subgroup of patients with ICA or MCA occlusion and reduced rCVR on entry, were significantly lower than in those with normal rCVR (P=0." | 2.70 | Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. ( Ogasawara, K; Ogawa, A; Yoshimoto, T, 2002) |
| "Moyamoya disease is characterized by bilateral progressive terminal internal carotid arteries steno-occlusion." | 1.46 | Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease. ( Boulahdour, H; Drouet, C; Morel, O; Porot, C; Thines, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Roder, C | 1 |
| Haas, P | 1 |
| Fudali, M | 1 |
| Milian, M | 1 |
| Ernemann, U | 1 |
| Meyer, PT | 1 |
| Tatagiba, M | 1 |
| Khan, N | 1 |
| Han, M | 1 |
| Kwon, I | 1 |
| Ha, J | 1 |
| Kim, J | 1 |
| Cha, MJ | 1 |
| Kim, YD | 1 |
| Heo, JH | 1 |
| Nam, HS | 1 |
| Haga, S | 1 |
| Morioka, T | 1 |
| Shimogawa, T | 1 |
| Akiyama, T | 1 |
| Murao, K | 1 |
| Kanazawa, Y | 1 |
| Sayama, T | 1 |
| Arakawa, S | 1 |
| Bahr-Hosseini, M | 1 |
| Shakur, SF | 1 |
| Amin-Hanjani, S | 1 |
| Charbel, FT | 1 |
| Alaraj, A | 1 |
| Drouet, C | 1 |
| Morel, O | 1 |
| Thines, L | 1 |
| Porot, C | 1 |
| Boulahdour, H | 1 |
| Chou, CW | 1 |
| Chang, JH | 1 |
| Lin, SZ | 1 |
| Cho, DY | 1 |
| Cheng, YW | 1 |
| Chen, CC | 1 |
| Yamauchi, H | 1 |
| Okazawa, H | 1 |
| Kishibe, Y | 1 |
| Sugimoto, K | 1 |
| Takahashi, M | 1 |
| Hori, A | 1 |
| Harada, M | 1 |
| Nishitani, H | 1 |
| Uno, M | 1 |
| Yamamoto, S | 1 |
| Watanabe, M | 1 |
| Uematsu, T | 1 |
| Takasawa, K | 1 |
| Nukata, M | 1 |
| Kinoshita, N | 1 |
| Ogasawara, K | 2 |
| Tomitsuka, N | 1 |
| Kobayashi, M | 1 |
| Komoribayashi, N | 1 |
| Fukuda, T | 1 |
| Saitoh, H | 1 |
| Inoue, T | 1 |
| Ogawa, A | 2 |
| Kimura, Y | 1 |
| Oku, N | 1 |
| Kajimoto, K | 1 |
| Katoh, H | 1 |
| Tanaka, MR | 1 |
| Takasawa, M | 1 |
| Imaizumi, M | 1 |
| Kitagawa, K | 1 |
| Hori, M | 1 |
| Hatazawa, J | 1 |
| Chen, A | 1 |
| Shyr, MH | 1 |
| Chen, TY | 1 |
| Lai, HY | 1 |
| Lin, CC | 1 |
| Yen, PS | 1 |
| Kuroda, S | 1 |
| Houkin, K | 1 |
| Kamiyama, H | 1 |
| Mitsumori, K | 1 |
| Iwasaki, Y | 1 |
| Abe, H | 1 |
| Yoshimoto, T | 1 |
3 trials available for acetazolamide and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
Topics: Acetazolamide; Arterial Occlusive Diseases; Blood Flow Velocity; Brain; Carotid Artery Thrombosis; C | 2002 |
Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it?
Topics: Acetazolamide; Aged; Blood Flow Velocity; Brain; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Ce | 2001 |
Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study.
Topics: Acetazolamide; Adult; Aged; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Ce | 2002 |
11 other studies available for acetazolamide and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
Topics: Acetazolamide; Adolescent; Adult; Aged; Cerebrovascular Circulation; Cognition Disorders; Cohort Stu | 2020 |
Collateral augmentation treatment with a combination of acetazolamide and head-down tilt in a rat ischemic stroke model.
Topics: Acetazolamide; Animals; Anticonvulsants; Carbonic Anhydrase Inhibitors; Head-Down Tilt; Infarction, | 2020 |
Arterial Spin Labeling Perfusion Magnetic Resonance Image with Dual Postlabeling Delay: A Correlative Study with Acetazolamide Loading (123)I-Iodoamphetamine Single-Photon Emission Computed Tomography.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carotid Artery, Internal; Carotid Stenosis; Cerebral Arterie | 2016 |
Angiographic Correlates of Cerebral Hemodynamic Changes With Diamox Challenge Assessed by Quantitative Magnetic Resonance Angiography.
Topics: Acetazolamide; Aged; Biomarkers; Carbonic Anhydrase Inhibitors; Carotid Artery Diseases; Cerebrovasc | 2016 |
Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease.
Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Humans; Infarction, Middle Cerebral Artery; Moyam | 2017 |
Extracranial-intracranial (EC-IC) bypass of symptomatic middle cerebral artery (MCA) total occlusion for haemodynamic impairment patients.
Topics: Acetazolamide; Adult; Aged; Female; Hemodynamics; Humans; Infarction, Middle Cerebral Artery; Intrac | 2012 |
Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer.
Topics: Acetazolamide; Adult; Aged; Carotid Stenosis; Cerebrovascular Circulation; Cysteine; Female; Humans; | 2002 |
Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Carotid | 2004 |
Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Humans; Infarction, Middl | 2006 |
Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain; Carotid Artery Diseases; Ce | 2006 |
Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
Topics: Acetazolamide; Aged; Aged, 80 and over; Basal Ganglia; Blood Circulation; Blood Flow Velocity; Blood | 2006 |